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ABSTRACT 
Background: The Biosocial Cognitive Theory (bSCT) hypothesizes two pathways linking 
dimensions of impulsivity to substance use. The first predicts that the association between 
reward sensitivity and substance use is mediated by positive outcome expectancies. The 
second predicts that the relationship between rash impulsiveness and substance use is 
mediated by refusal self-efficacy. This model has received empirical support in studies of 
alcohol use. The present research provides the first application of bSCT to a cannabis 
treatment population and aims to extend its utility to understanding cannabis use and severity 
of dependence.   
Design: 273 patients referred for cannabis treatment completed a clinical assessment that 
contained measures of interest.  
Setting: A public hospital alcohol and drug clinic.  
Measurements: The Sensitivity to Reward Scale, Dysfunctional Impulsivity Scale, Cannabis 
Expectancy Questionnaire, Cannabis Refusal Self-Efficacy Questionnaire and Severity of 
Dependence Scale–Cannabis were completed, along with measures of cannabis consumption.   
Findings: The bSCT model provided a good fit to the data for cannabis use and severity of 
dependence outcomes. The association between reward sensitivity and each cannabis 
outcome was fully mediated by positive cannabis expectancies and cannabis refusal self-
efficacy. The relationship between rash impulsiveness and each cannabis outcome was fully 
mediated by cannabis refusal self-efficacy. 
Conclusions: Findings support the application of the bSCT model to cannabis use and 
dependence severity and highlight the important role of social cognitive mechanisms in 
understanding the association between impulsivity traits and these outcomes. The differential 
association of impulsivity traits to social cognition may assist targeted treatment efforts.  
Keywords: cannabis, dependence, expectancies, impulsivity, marijuana, self-efficacy 
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1. INTRODUCTION 
Cannabis is the most commonly used illicit drug worldwide (Hall, 2015). The global 
number of cannabis users is estimated at approximately 125 – 203 million people, or 2.8% - 
4.5% of the global population (Degenhardt and Hall, 2012). Of those who ever try cannabis, 
it is estimated that 10% will become daily users and 20 – 30% will become weekly users 
(Hall and Pacula, 2003). Engaging in frequent and persistent cannabis use is associated with 
increased risk for adverse outcomes including cannabis dependence (Hall and Degenhardt, 
2009), long-term cognitive impairments (Solowij et al., 2002) and psychosis (van Os et al., 
2002). The effectiveness of secondary prevention and treatment interventions will be 
enhanced by an understanding of the risk factors and psychological processes that influence 
and maintain cannabis use and dependence.  
Impulsivity and cannabis-related cognition are two sets of psychological risk factors 
associated with cannabis consumption (Hayaki et al., 2010; Lyvers et al., 2013; Stautz et al., 
2017), cannabis dependence (Blanco et al., 2014; Connor et al., 2013; Hayaki et al., 2011) 
and treatment outcomes (Bentzley et al., 2016; Gullo et al., 2017b; Litt et al., 2008). The 
Biosocial Cognitive Model (bSCT model) integrates biologically-based personality traits and 
social cognitive factors to provide a mechanistic account of substance use. In summary, this 
model predicts that impulsivity conveys risk for cannabis use through its influence on 
cannabis related-learning and cannabis-related cognitions. The present study will evaluate 
this model in a sample of cannabis users in treatment.   
1.1 Impulsivity  
Impulsivity plays a key role in substance use disorders. Current evidence indicates 
that impulsivity is comprised of two biologically-based dimensions which independently 
contribute to the development of drug abuse and dependence (Dawe et al., 2004; DeWit and 
Richards, 2004; Potenza and Taylor, 2009; Woicik et al., 2009). These dimensions are 
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reward sensitivity (reward drive) and rash impulsiveness (disinhibition). At the trait level, 
reward sensitivity reflects individual differences in the inherent salience of rewarding stimuli. 
Reward sensitive individuals are more likely to notice, desire and actively pursue rewards, 
including drugs of abuse. Conceptually, it is similar to Sensation Seeking (Steinberg, 2010; 
Woicik et al., 2009), Choice Impulsivity (Potenza and Taylor, 2009), and particularly Gray's 
(1970) Behavioural Approach System. The other trait, rash impulsiveness, refers to individual 
differences in the capacity to modulate and inhibit prepotent approach behaviours, regardless 
of potential negative consequences. Rash impulsive individuals have a tendency to persist in 
previously reinforced behaviour, despite that behaviour no longer resulting in reward (Gullo 
and Dawe, 2008).  Conceptually, it is similar to Impulsivity (Steinberg, 2010; Woicik et al., 
2009), Response Impulsivity (Potenza and Taylor, 2009), and Barratt's (1972) Impulsiveness 
dimension.  
While each trait bears similarities to other constructs, there are important differences 
(e.g., Carlson et al., 2013; Gullo et al., 2014a). For example, it is high reward sensitivity in 
particular that is argued to drive the learning bias that produces stronger associations between 
cannabis cues and anticipated reward (i.e., positive cannabis expectancies; Gullo et al., 2010). 
While Sensation Seeking and Choice Impulsivity may also be related to positive 
expectancies, theoretically, it should only be those components related to reward sensitivity 
that are behind this association (Gray, 1975; Gullo et al., 2010). Similarly, while there is less 
variance among rash impulsiveness-like traits, it has been argued that it is those components 
related to disinhibition and non-planning, as conceptualized in rash impulsiveness, that affect 
beliefs about control over cannabis (i.e., cannabis refusal self-efficacy; Gullo et al., 2010). 
Both impulsivity traits are associated with greater cannabis use (Griffith-Lendering et al., 
2012; Lyvers et al., 2013; Prince van Leeuwen et al., 2011; Stautz et al., 2017).  
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1.2 Biosocial Cognitive Theory  
Biologically-based personality traits, like reward sensitivity and rash impulsiveness, 
are distal risk factors for drug abuse. One mechanism through which these traits are predicted 
to influence drug use is via their influence on social learning (Bandura, 1986), and the 
subsequent acquisition and maintenance of drug-related cognitions (Gullo et al., 2010; Smith 
and Anderson, 2001). These proximal, cognitive risk factors directly influence drug use. The 
bSCT model (see Figure 1) proposes that reward sensitivity and rash impulsiveness convey 
risk for substance use via two distinct, cognitively-mediated pathways. 
 The first pathway involves reward sensitivity influencing cannabis use via its effect 
on positive cannabis expectancies (i.e., the set of expectations that consuming cannabis will 
result in positive outcomes; Gullo et al., 2010; Papinczak et al., 2018). Highly reward 
sensitive individuals are predicted to experience a positive learning bias, in which they are 
more likely to attend to, encode, and recall the positive effects of using cannabis (Gullo et al., 
2010; Smith and Anderson, 2001). They may also experience greater euphoria and 
reinforcement from cannabis use. Therefore, these individuals are prone to acquire and 
maintain strong positive cannabis expectancies. Positive cannabis expectancies are robustly 
associated with greater cannabis consumption and this effect has been demonstrated among 
adolescents (Alfonso and Dunn, 2007; Skenderian et al., 2008), adults (Brackenbury et al., 
2016; Galen and Henderson, 1999) and cannabis dependent individuals (Boden et al., 2013; 
Connor et al., 2013, 2011).   
The second pathway involves rash impulsiveness influencing cannabis use through its 
effect on cannabis refusal self-efficacy (i.e., self-confidence in one’s ability to refuse 
cannabis; Gullo et al., 2010; Papinczak et al., 2018). Rash impulsive individuals have 
inherent difficulties in inhibitory control, particularly during situations involving the refusal 
of immediate rewards. Reduced cannabis refusal self-efficacy is considered to result, in part, 
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from a generalized belief of poor impulse control due to past failures to refuse rewards (Gullo 
et al., 2010). Therefore, these individuals are predicted to have greater self-perceived 
difficulty resisting cannabis, which is then reinforced by subsequent disinhibited use. 
Cannabis refusal self-efficacy is a robust predictor of cannabis consumption, and is 
negatively associated with cannabis use among frequent users (Connor et al., 2013; Hayaki et 
al., 2011; Young et al., 2012). Cannabis refusal self-efficacy is also an important predictor of 
abstinence during and after the treatment of cannabis dependence (Kadden et al., 2007; Litt et 
al., 2008; Litt and Kadden, 2015) and is negatively associated with cannabis dependence 
severity (Connor et al., 2013; Young et al., 2012).  
In addition to directly impacting cannabis use, positive cannabis expectancies 
indirectly influence use via their effect on cannabis refusal self-efficacy. Theoretically, higher 
perceived reinforcement from drug use will undermine self-efficacy for drug refusal 
(Bandura, 1986; Gullo et al., 2010). Cannabis refusal self-efficacy has been found to fully 
mediate the association between positive cannabis expectancies and cannabis use in studies 
of university students (Papinczak et al., 2018) and cannabis dependent outpatients (Gullo et 
al., 2017b), and partially mediated this association in a study of cannabis users referred for 
treatment (Connor et al., 2013).  
The majority of the empirical evidence in support of the bSCT model has been 
obtained from studies of alcohol use. These studies have examined a range of different 
samples including university students (Gullo et al., 2010; Harnett et al., 2013; Leamy et al., 
2016), adults recruited from the community (Kabbani and Kambouropoulos, 2013) and 
alcohol dependent inpatients (Gullo et al., 2014b, 2010). Only one study has examined the 
bSCT model in the context of cannabis use. Papinczak and colleagues (2018) recently 
evaluated the model in a study of youth cannabis use and obtained cross-sectional data from a 
sample of 252 university students. This study found that the bSCT model provided a good fit 
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to the data. Positive cannabis expectancies and cannabis refusal self-efficacy partially 
mediated the relationship between reward sensitivity and cannabis use. Cannabis refusal self-
efficacy on the other hand, fully mediated the association between rash impulsiveness and 
cannabis use. While this initial evidence is promising, the results of Papinczak et al. (2018) 
may be limited by the infrequent use of cannabis reported by the sample. 
1.3 Present Study 
 It is not known whether social cognition would serve to mediate the association of 
impulsivity with cannabis use in a treatment population. Furthermore, there may be 
differences in the strength of the model pathways when comparing a clinical sample to a 
student sample, as has been previously found in alcohol studies (Gullo et al., 2014b, 2010; 
Leamy et al., 2016). If found, such differences could have important implications for targeted 
approaches to cannabis prevention and treatment, through highlighting distinct pathways of 
risk.  
The present study provides the first test of a new Biosocial Cognitive Theory in 
cannabis users referred for treatment. This research will test the bSCT model across two 
outcomes: cannabis use and cannabis dependence severity. To summarise, the bSCT model 
hypothesizes that (see Figure 1):  
1. Cannabis refusal self-efficacy will mediate the association between rash 
impulsiveness and cannabis outcomes.   
2. Positive cannabis expectancies will mediate the association between reward 
sensitivity and cannabis outcomes.  
3. Cannabis refusal self-efficacy will mediate the association between positive 
cannabis expectancies and cannabis outcomes.  
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2. METHOD 
2.1 Participants and Procedure 
 Data were obtained from all 346 cannabis users who attended a cannabis assessment 
between 1 February 2016 and 30 September 2017 as part of the Queensland Illicit Drug 
Diversion Initiative. All patients attended this diversion program voluntarily and under police 
direction as an alternative to criminal prosecution for a minor cannabis-related offence (i.e., 
possession of <50g of cannabis or paraphernalia).
1
 The diversion program consists of a two-
hour assessment of substance use and psychosocial functioning and incorporates motivational 
interviewing. As part of the assessment protocol, all patients who attend the diversion 
program complete an assessment battery that includes the measures listed in Section 2.2. 
These completed assessment batteries were analysed in the present study. The present study 
analysed cases from consecutive patients who presented at a public hospital alcohol and drug 
clinic in Brisbane, Australia during the study period. Ethics approval was obtained from the 
hospital human ethics committee to access de-identified, retrospective data for patients in the 
diversion program. The response rate was 100% of individuals assessed at the site.  
2.2 Measures 
Reward sensitivity was measured using the 10-item version of the Sensitivity to 
Reward Scale (Cooper and Gomez, 2008).  Each item describes a behaviour in which a yes 
(1) or no (0) response is made. The convergent, concurrent and discriminant validity of the 
scale has been established (Cooper and Gomez, 2008). Factor analytic studies have shown it 
loads on a factor with measures of the same construct (e.g., BAS-Drive; Franken and Muris, 
2006). 
Rash impulsiveness was measured using the 12-item Dysfunctional Impulsivity Scale 
(Dickman, 1990). Each item describes a behaviour in which a true (1) or false (0) response is 
                                                     
1
 No other types of crimes are offered the option to attend the diversion program. There is currently no data 
available on the number of individuals who decline drug diversion, but anecdotal reports by police suggest that 
“everyone” chooses it over prosecution.  
BIOSOCIAL COGNITIVE MODEL OF CANNABIS USE AND DEPENDENCE 9 
made. The criterion validity of the scale has been confirmed (e.g., delay discounting; Mobini 
et al., 2007) and it loads on a factor with measures of the same construct (e.g., Novelty 
Seeking;  Miller et al., 2004).  
Positive cannabis expectancies were assessed using the positive expectancies scale 
(18 items) from the Cannabis Expectancy Questionnaire (CEQ-P) (Connor et al., 2011). 
Responses were rated on a 5-point Likert scale (1 = Strongly disagree to 5 = Strongly agree). 
The criterion validity and factor structure of the scale have been confirmed (Connor et al., 
2011).  
Cannabis refusal self-efficacy was measured using the 14-item Cannabis Refusal Self-
Efficacy Questionnaire (CRSEQ) (Young et al., 2012). It comprises three subscales that can 
be summed to provide a total score: emotional relief (six items) opportunistic (five items) and 
social facilitation (three items). Responses were made on a 6-point Likert scale (1 = I am 
very sure I could NOT resist smoking cannabis to 6 = I am very sure I could resist smoking 
cannabis). The factor structure and criterion validity of the CRSEQ has been previously 
established in clinical samples (Young et al., 2012).  
Severity of cannabis dependence was determined using the five-item Severity of 
Dependence Scale – Cannabis (SDS-C) (Gossop et al., 1995). This measure assesses the 
degree of psychological dependence experienced by users (Swift et al., 2000). The SDS-C 
cut-off for DSM-IV cannabis dependence is a score greater than 2, which corresponds with 
64% sensitivity and 82% specificity (Swift et al., 1998). The construct and criterion validity 
of the SDS-C has been confirmed in adult and adolescent samples of cannabis users (Ferri et 
al., 2000; Martin et al., 2006). The SDS-C was used as a continuous indicator of severity of 
cannabis dependence in the present study. 
Cannabis use was assessed using a single item in which patients indicated the typical 
“quantity of cannabis used per week” in the past month and responded using an open-
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response format to indicate grams used per week . That is, “_______grams/week”. The 
convergent validity of this item was evidenced by a small significant correlation with SDS-C 
scores (r = .32) in the present sample which is consistent with correlations reported in past 
research (Ferri et al., 2000; Steiner et al., 2008). 
2.3 Data Analyses 
Structural equation modelling with robust maximum likelihood estimation was 
conducted in R using the lavaan package. The comparative fit index (CFI), Tucker Lewis 
index (TLI), goodness-of-fit index (GFI),  root mean square error of approximation 
(RMSEA) and standardized root mean square residual (SRMR) were used to evaluate model 
fit. The following cut-offs were used to indicate “good” fit: CFI  0.95; TLI  0.95; GFI  
0.90; RMSEA  0.06; SRMR  0.08 (Hooper et al., 2008; Hu and Bentler, 1999). The 2 test 
of model fit (alpha = 0.05) is also reported, although this typically overestimates poor fit in 
large samples (Bentler, 2007). The final useable sample was n = 269; further details 
concerning data analyses, data screening and assumption checks are reported in the 
Supplementary Material.  
3. RESULTS 
Sample characteristics are presented in Table 1. Descriptive statistics and Cronbach’s 
alphas for the model variables are reported in Table 2. The inter-correlations between model 
variables are reported in Table 3. The fit indices for the structural models are presented in 
Table 4. Results of the 2 difference tests (2) indicated no difference between partial and 
full mediation models, which supports the latter, more parsimonious model (see Table 4). 
This is consistent with the direct pathways which were non-significant. Reward sensitivity 
was not directly associated with cannabis use (  = .14,  p=.090) or severity of cannabis 
dependence (  = .11, p=.097). Rash impulsiveness was not directly associated with cannabis 
use (  = .03,  p=.701) or dependence severity (  = .05, p=.415). In the following sections, the 
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full mediation model pathways are reported in the text and figures. The direct effects of the 
structural models are reported in Table 5.  
3.1 Cannabis Use 
The bSCT model provided a good fit to the data (see Table 4, Models 1 and 2). The 
model pathways are reported in Figure 2. Overall, the model explained 18.9% of the variance 
in cannabis use, which is a moderate-to-large effect size (Cohen, 1988). Hypothesis 1 was 
supported as a significant mediation effect was found for the rash impulsiveness pathway 
(unstandardized indirect effect = 0.347, 97.5% CI = 0.191 – 0.533). Rash impulsiveness was 
directly associated with lower levels of cannabis refusal self-efficacy (p<.001) and this 
association had a moderate effect size (  = -0.36). Cannabis refusal self-efficacy was directly 
associated with lower levels of cannabis use (p<.001) and this was a moderate effect size (  
= -0.38).  
Hypothesis 2 was supported as a significant mediation effect was found for the reward 
sensitivity pathway (unstandardized indirect effect = 0.060, 97.5% CI = 0.006 – 0.139). 
Reward sensitivity was directly associated with stronger positive cannabis expectancies 
(p=.006). Stronger positive cannabis expectancies were associated with greater cannabis use 
– both directly (p=.017) and indirectly via reduced levels of refusal self-efficacy (p<.001; 
unstandardized indirect effect = 0.246, 97.5% CI = 0.135 – 0.379). Therefore, Hypothesis 3 
was supported.  
3.2 Cannabis Dependence Severity 
The bSCT model provided a good fit to the data (see Table 4, Models 3 and 4).  The 
model pathways are shown in Figure 3. Overall, the model explained 30.6% of the variance 
in severity of cannabis dependence, which is a large effect size (Cohen, 1988). Hypothesis 1 
was supported as a significant mediation effect was found for the rash impulsiveness pathway 
(unstandardized indirect effect = 0.179, 97.5% CI = 0.111 – 0.256). Rash impulsiveness was 
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directly associated with lower levels of cannabis refusal self-efficacy (p<.001) and this effect 
was moderate (  = -0.37). Cannabis refusal self-efficacy was directly associated with severity 
of cannabis dependence (p<.001) and this association had a large effect size (  = -0.55).  
Hypothesis 2 was supported as a significant mediation effect was found for the reward 
sensitivity pathway. Reward sensitivity was directly associated with greater positive cannabis 
expectancies (p=.006), which were associated with severity of cannabis dependence 
indirectly via reduced refusal self-efficacy (unstandardized indirect effect = 0.123, 97.5% CI 
= 0.075 – 0.178). This supported Hypothesis 3. Positive cannabis expectancies were not 
directly associated with severity of cannabis dependence (p=.905).  
4. DISCUSSION 
 This study provides primary support for the generalizability of the Biosocial 
Cognitive Theory (bSCT) to cannabis use and severity of cannabis dependence. The bSCT 
model was able to predict a moderate-to-large amount of variance in typical weekly cannabis 
use and severity of cannabis dependence within a group of cannabis users referred for 
treatment. Overall, the results of the two models were consistent. The social cognitive 
mechanisms of positive expectancies and refusal self-efficacy fully mediated the effects of 
reward sensitivity and rash impulsiveness, respectively. Therefore, these results provide a 
theoretical explanation for how these biologically-based impulse personality traits convey 
risk for cannabis use and dependence. 
The two mediational pathways proposed by bSCT were supported in this study. Our 
results suggest that cannabis refusal self-efficacy may be an important mechanism through 
which rash impulsiveness indirectly influences cannabis use and dependence. This is in line 
with the prediction that rash impulsive individuals have greater perceived difficulty refusing 
substances, possibly due to past failed attempts to refuse rewards generally and awareness of 
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difficulties with inhibitory control (Gullo et al., 2010). This weakened sense of refusal self-
efficacy may place rash impulsive individuals at greater risk for problematic cannabis use. 
The reward sensitivity pathway was more complex. Our findings suggest that reward 
sensitivity is associated with cannabis use and dependence indirectly through the mechanism 
of positive cannabis expectancies and its subsequent negative association with cannabis 
refusal self-efficacy. Reward sensitivity was associated with stronger positive cannabis 
expectancies, which is consistent with the notion of a positive learning bias in the context of 
substance use (Gullo et al., 2010). These heightened positive expectancies among reward 
sensitive individuals, may place them at greater risk for cannabis use and dependence, 
theoretically through undermining their refusal self-efficacy.  
The results of this study are consistent with Social Cognitive Theory's prediction that 
self-efficacy is the key, proximal predictor of behaviour (Bandura, 1986). As has previously 
been found with alcohol, cannabis refusal self-efficacy had the strongest, direct association 
with cannabis use (moderate effect size) and severity of dependence (large effect size), and it 
provided the mechanism through which positive expectancies conveyed the majority of their 
association with these outcomes. Together, these results add to the body of literature 
highlighting the important protective role that refusal self-efficacy plays against problematic 
cannabis use (Hayaki et al., 2011; Young et al., 2012); and indicate that refusal self-efficacy 
is an important target for cannabis interventions (Kadden and Litt, 2011).   
Based upon the findings of the present study, the bSCT may reveal new avenues for 
targeted treatments. Of proximal importance is refusal self-efficacy, consistent with previous 
studies, which can be increased directly and indirectly through several different approaches. 
Teaching and practicing coping skills to better manage high risk situations, and the sense of 
mastery that comes with it, is one way to increase self-efficacy (Bandura, 1986; Litt et al., 
2008; Marlatt and Gordon, 1985; Stephens et al., 1995). According to bSCT, the 
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prioritization of coping skills to develop could be informed by consideration of patient 
characteristics. For example, given the similar magnitude of the association with self-efficacy 
between rash impulsiveness and positive expectancies, a patient with higher expectancies 
may benefit more from behavioural experiments and cognitive restructuring skills that target 
their exaggerated beliefs (Beck et al., 1993; Brown, 1993). Our findings also suggest that 
individuals high in rash impulsiveness may be at greater risk of large reductions in cannabis 
refusal self-efficacy after a lapse, increasing the likelihood of relapse (Marlatt and Gordon, 
1985). Treatment targeted at individuals high in rash impulsiveness may involve a greater 
degree of relapse prevention support. If a causal connection is found to exist between rash 
impulsiveness and cannabis refusal self-efficacy, rash impulsiveness could be targeted 
directly through process-oriented techniques included in cognitive and dialectical behavioural 
therapies (Butz and Austin, 1993; Coates et al., 2018; Lineham, 1993).  
The results of the present study are largely consistent with past research which has 
evaluated the bSCT in the context of alcohol abuse and dependence (Gullo et al., 2014b, 
2010; Harnett et al., 2013; Kabbani and Kambouropoulos, 2013) and cannabis use (Papinczak 
et al., 2018). This consistency across studies suggests that the same social cognitive 
mechanisms are operating across substances of abuse and levels of use, and are consistently 
and uniquely, associated with different dimensions of impulsivity. Therefore, the bSCT 
model is likely to apply to substance use, broadly. Further research is required to confirm this 
for other substances, although, it raises the possibility of common pathways of risk that could 
be targeted to reduce or prevent problematic substance use.  
Despite some similarities across studies, there were important differences between the 
results of the present research and Papinczak et al. (2018), who evaluated the bSCT model of 
cannabis use in a sample of university students. First, unlike Papinczak et al. (2018), there 
was no direct association between reward sensitivity and the cannabis outcomes in the 
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present clinical sample as effects were fully mediated by positive expectancies. Second, both 
cannabis use and dependence severity were more strongly associated with the rash 
impulsiveness pathway in the clinical sample, compared to university students. These 
findings suggest that the reward sensitivity pathway may be more influential during the 
initiation and experimental phases of cannabis use, while the rash impulsiveness pathway 
may play a stronger role in abuse and dependence. This suggests that there may be benefits to 
targeting different bSCT pathways and mechanisms when approaching cannabis use 
prevention versus treatment for dependence.  
Some limitations in the present study are acknowledged. Firstly, the study was cross-
sectional in its design and therefore the directions of the observed effects and causality 
cannot be determined. Secondly, there may be limitations to the generalisability of the 
findings  as the sample was a group of cannabis users who were offered treatment as part of a 
police-mandated program and attended voluntarily as an alternative to criminal prosecution. 
Given this treatment context, there may be an increased likelihood of participants under 
reporting their cannabis use, however, at the commencement of the session, participants were 
assured of the confidentiality of their responses.  Thirdly, the self-report SDS-C was used to 
assess dependence severity, rather than clinical interviews. Furthermore, although the SDS-C 
has been validated on DSM-IV criteria, it has not yet been validated for DSM-5 cannabis use 
disorder. Fourthly, cannabis use was assessed with a single-item in which participants 
indicated the typical quantity of cannabis they consumed per week during the past month. 
Although typical use measures are commonly used, they provide a less precise indication of 
actual use in comparison to the timeline followback method (Sobell & Sobell, 1992). Based 
upon these limitations, future research could utilise a community sample of cannabis users 
and would benefit from employing a longitudinal design, clinical interviews to diagnose 
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DSM-5 cannabis use disorder and the timeline followback to measure cannabis consumption 
with corroboration from biochemical measures (Smith et al., 2018).  
  To conclude, this research supported bSCT when applied to the understanding of 
cannabis use and severity of cannabis dependence in a clinical population. The findings offer 
an explanation for how biologically-based impulsive personality traits convey risk for 
problematic cannabis use at the cognitive level of analysis. Future treatments for problematic 
cannabis use could be enhanced by focusing on the complex interplay of bSCT factors. 
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Table 1 
Sample characteristics (N = 273). 
 M SD Range 
Age (years) 26.31 9.39 14 - 61 
Cannabis use – typical weekly 
consumption (grams) 
4.06 10.09 0 - 70 
Cannabis use – number of days in the last 
28 (days) 
9.58 10.09 0 - 28 
Cannabis use – age of first use (years) 17.17 4.80 7 - 54 
Hazardous drinking (AUDIT score) 7.12 6.18 0 - 34 
 N n % 
Gender 
       Female 
       Male 
 
273 
 
60 
213 
 
22 
78 
Country of Birth    
        Australia           
        New Zealand  
        England         
        Other (not specified)                                   
 
273 
 
206 
14 
10 
43 
 
75.5 
5.1 
3.7 
15.8 
Finished High School 
       Yes 
       No 
 
270 
 
206 
64 
 
76.3 
23.7 
Aboriginal or Torres Strait Islander 
       Neither         
       Aboriginal 
       Torres Strait Islander 
 
271 
 
264 
6 
1 
 
97.4 
 2.2 
0.4 
Currently Employed 
      Yes 
      No 
 
272 
 
222 
50 
 
81.6 
18.4 
Receiving Government Benefits 
     Yes 
     No 
 
272 
 
61 
211 
 
22.7 
77.3 
SDS Cannabis Dependent     
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      Yes 
      No 
270 104 
166 
38.5 
61.6 
Cannabis Primary Drug of Concern 
      Yes 
      No 
 
267 
 
246 
21 
 
92.1 
7.9 
Cannabis Used in Past 28 Days 
      Yes 
      No 
 
250 
 
217 
33 
 
86.8 
13.2 
Usual Frequency of Cannabis Use  
      0 days per week 
      1-3 days per week 
      4-6 days per week 
      Daily 
      Fortnightly 
     Opportunistically 
     Monthly 
 
253 
 
2 
82 
17 
73 
17 
55 
7 
 
0.8 
32.4 
6.7 
28.9 
6.7 
22.7 
2.8 
Tobacco Smoker 
     Yes 
     No 
 
273 
 
62 
211 
 
22.7 
77.3 
 Note. SDS = Severity of Dependence Scale; AUDIT = Alcohol Use Disorders Identification 
Test.  
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Table 2 
Means, standard deviations and Cronbach’s alphas of the measured variables (N = 273). 
 Scale M SD   
Sensitivity to Reward Scale
a 
 4.05 2.52 .72 (.83) 
Dysfunctional Impulsivity Scale
b
   3.04 2.94 .64 (.90) 
Cannabis Expectancy Questionnaire  
    Positive
c
  
 
51.69 
 
12.48 
 
.92 
Cannabis Refusal Self-Efficacy 
Questionnaire
 
Emotional Relief
d
 
    Opportunistic
d
 
    Social Facilitation
d
  
 
 
27.76 
21.24 
15.32 
 
 
8.81 
7.08 
3.50 
 
 
.97 
.92 
.87 
Severity of Cannabis Dependence Scale
e
 2.26 2.48 .77 
Note. All sum scores. The poly-choric Cronbach’s alphas of the dichotomous scales are 
presented in brackets. 
a
Higher scores reflect greater reward sensitivity.  
b
Higher scores reflect greater rash impulsiveness.  
c
Higher scores reflect higher positive cannabis outcome expectancies. 
d
Higher scores reflect greater cannabis refusal self-efficacy. 
e
Higher scores reflect greater cannabis dependence severity.  
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Table 3 
Pearson’s correlations between the measured variables (N = 273). 
 
Variable 1. 2. 3. 4. 5. 6. 7. 8. 
1. Reward sensitivity  -        
2. Rash impulsiveness .23
***
 -       
3. Positive cannabis 
expectancies 
.16
*
 .03 -      
4. Emotional relief refusal 
self-efficacy 
-.15
*
 -.38
***
 -.30
***
 -     
5. Opportunistic refusal 
self-efficacy 
-.18
**
 -.27
***
 -.28
***
 .76
***
 -    
6. Social facilitation refusal 
self-efficacy 
-.03 -.24
***
 -.31
***
 .74
***
 .65
***
 -   
7. Cannabis use .22
**
 .21
**
 .25
***
 -.37
***
 -.36
***
 -.32
***
 -  
8. Severity of cannabis 
dependence 
.20
**
 .30
***
 .22
***
 -.54
***
 -.42
***
 -.35
***
 .32
***
 - 
Note. *p<.050; **p<.010; ***p<.001 
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Table 4 
Fit Indices for the Hypothesized Structural Models (n = 269).  
 
Model 2(df) CFI TLI GFI NFI RMSEA 
(CI90%) 
SRMR 2(df) 
1. Full Mediation Model – 
cannabis use 
54.92
*
 
(24) 
.97 .96 .997 .95 .07 (.05 - .10) .04  
2. Partial Mediation Model – 
cannabis use 
48.08
*
 
(22) 
.98 .96 .997 .96 .07 (.04 - .10) .03  
3. Full Mediation Model – 
severity of dependence 
54.04
* 
(24) 
.97 .96 .997 .95 .07 (.05 - .10) .04  
4. Partial Mediation Model – 
severity of dependence  
48.70
*
 
(22) 
.98 .96 .997 .98 .07 (.04 - .10) .03  
Difference between Model 1 and 
2 
       5.94
#
 (2) 
 
Difference between Model 3 and 
4 
       5.34
^
 (2) 
Note. CFI = comparative fit index; TLI = Tucker Lewis index; GFI = goodness-of-fit index; NFI = normed fit index; RMSEA = root mean-
square error of approximation; SRMR = standardized root mean square residual.  
*p <.001; #p= .050; ^p = .070 
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Table 5 
Summary of Direct Effects from the Biosocial Cognitive Models (n = 269).  
 
Pathway Standardized Coefficients 
(ß) 
Unstandardized 
Coefficients 
Standard Error (SE) p-value 
Cannabis Use     
RS  PCE .18 .30 .11 .006 
PCE  CRSE -.37 -.75 .13 <.001 
PCE  Can Use .11 .20 .08 .017 
CRSE  Can Use -.38 -.33 .06 <.001 
RI  CRSE -.36 -1.06 .18 <.001 
Severity of Dependence     
RS  PCE .18 .30 .11 .006 
PCE  CRSE -.37 -.75 .13 <.001 
PCE  Can Dep .01 .01 .05 .905 
CRSE  Can Dep -.55 -.16 .02 <.001 
RI  CRSE -.37 -1.09 .18 <.001 
Note. RS = Reward Sensitivity; RI = Rash Impulsiveness; PCE = Positive Cannabis Expectancies; CRSE = Cannabis Refusal Self-Efficacy; Can 
Use = Cannabis Use; Can Dep = Severity of Cannabis Dependence.  
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Figure  3.
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Figure Captions 
 
Figure 1. Biosocial Cognitive Model of Cannabis Use and Cannabis Dependence Severity. 
 
Figure 2. The Biosocial Cognitive Model of Cannabis Use. Standardized parameter estimates 
are presented. All estimates are statistically significant at p<.05.  
 
Figure 3. The Biosocial Cognitive Model of Severity of Cannabis Dependence. Standardized 
parameter estimates are presented. All estimates are statistically significant at p<.05, except 
where indicated (ns). 
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 HIGHLIGHTS 
 Impulsivity associated with cannabis use and dependence via social cognition. 
 Reward sensitivity associated with cannabis outcomes via positive expectancies. 
 Rash impulsiveness associated with cannabis outcomes via refusal self-efficacy.  
 Targeting social cognition may reduce risk conveyed by an impulsive personality. 
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Data Analyses 
Total scores on the three subscales of the CRSEQ served as indicators for the latent 
cannabis refusal self-efficacy factor (Young et al., 2012). For the positive cannabis 
expectancies latent factor, random parcels of items from the CEQ-P were formed to create the 
indicators as the CEQ-P is a unidimensional scale (Little et al., 2002; Matsunaga, 2008). As 
the measures of reward sensitivity and rash impulsiveness contained a smaller number of 
dichotomously-scored items (10-12 items), these personality constructs were modelled as 
single-indicator latent variables, each with their measurement error set as 1 – Cronbach’s alpha 
(Bollen, 1989; Sass and Smith, 2006). Cannabis use (grams) and severity of dependence (SDS-
C total score) were modeled as non-latent measured variables, as in Connor et al. (Connor et 
al., 2013). 
Mediation was tested in two ways. First, the fit of the hypothesized bSCT model 
(specifying full mediation) was compared to that of a partial mediation bSCT model that 
specified direct associations between impulsivity traits and cannabis outcomes. Models were 
compared using the 2 difference test (2) (Holmbeck, 1997). Second, the indirect mediation 
effect itself was estimated using RMediation package, which utilises the distribution-of-the-
product method (Tofighi and MacKinnon, 2011). Robust standard errors were used when 
calculating the indirect effects (Preacher, 2015). 
Data Screening and Assumption Checks 
The original data set contained the responses of 346 previously unanalysed cases. 
Overall, there was 14.1% missing data. 52 participants were missing more than 50% of their 
data and thus were excluded from further analyses. A further 21 participants were excluded as 
they had not completed any items on at least one of the model measures. A sample size of 273 
remained, in which there was 0.82% missing data. Data were missing completely at random 
(MCAR) as Little’s (Little, 1988) MCAR test was non- significant, 𝜒2(181) = 180.41, p =0.498. 
Missing data were estimated using the Full Information Maximum Likelihood method 
(Graham, 2009).   
 The data were screened for outliers and this revealed that 12 participants were 
univariate outliers and 4 participants were multivariate outliers. The multivariate outliers 
significantly reduced multivariate normality and inflated model fit and therefore were excluded 
from further analyses, leaving 269 cases. While this improved multivariate normality, Mardia’s 
test revealed that this assumption was still violated in both the cannabis use model (normalized 
coefficient = 29.90, p<.001) and severity of dependence model (normalized coefficient = 7.27, 
p<.001). Therefore, Yuan- Bentler corrected model fit statistics and Huber-White robust 
standard errors were used across the analyses to control for any potential biases (Rosseel, 2012; 
Tong et al., 2014; Yuan and Bentler, 2000).  
The models were re-run controlling for the effects of sex, age, hazardous alcohol use 
(as indicated by total scores on the Alcohol Use Disorders Identification Test [AUDIT; 
(Saunders et al., 1993)] and psychological functioning (as indicated by total scores on the 
General Health Questionnaire [GHQ-28, (Goldberg and Williams, 1998)]. Results were 
unaffected. Neither sex nor age were significantly associated with the cannabis outcomes, 
consistent with Connor et al. (2013). Similarly, hazardous alcohol use and psychological 
functioning were not associated with cannabis use or severity of cannabis dependence. 
Therefore, these were not retained in the final models.  
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